Back to search

France· FR:65659614

REBETOL 40 mg/ml, solution buvable

A medicinal product containing ribavirine, registered in France by MERCK SHARP & DOHME (PAYS-BAS), on the national reimbursement list.

Reimbursed in France (Assurance maladie)

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedREBETOL 40 mg/ml, solution buvableATC—REGISTER NO.FR:65659614PACKS LISTED1CHECKEDSeptember 12, 2026

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
RIBAVIRINE
Manufacturer
MERCK SHARP & DOHME (PAYS-BAS)
Country
France (FR)
ATC code
—
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400936586680
    1 flacon(s) en verre jaune(brun) de 100 ml avec fermeture de sécurité enfant avec seringue(s) pour administration orale polyéthylène polystyrène
    EUR 87.9

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Ribavirine in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ribavirine products

Authorised across Europe · EMA

The same active substance is authorised in 7 EEA countries. Names it is sold under:

  • Cyprus · Ribavirin Aurobindo
  • Germany · Ribavirin Ratiopharm
  • Spain · Ribavirina Normon
  • United Kingdom (Northern Ireland) · Ribavirin Milpharm
  • Italy · Ribavirina Aurobindo
  • Netherlands · Ribavirine Ratiopharm
  • Portugal · Ribavirina Aurobindo

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/12ce1ae5-275b-4b05-877b-b403426e7ee2
GET /v1/drugs/12ce1ae5-275b-4b05-877b-b403426e7ee2?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "65659614",
  "date_amm": "2005-01-25",
  "type_amm": "Procédure centralisée",
  "numero_ue": "EU/1/99/107",
  "substance": "RIBAVIRINE",
  "statut_amm": "Autorisation abrogée",
  "statut_bdm": "Warning disponibilité",
  "forme_pharmaceutique": "solution buvable",
  "voies_administration": "orale",
  "etat_commercialisation": "Non commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about ribavirine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.